Overview

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject

Status:
Not yet recruiting
Trial end date:
2023-03-20
Target enrollment:
Participant gender:
Summary
The study is being conducted to Evaluate the Safety, Tolerability and Pharmacokinetics pharmacodynamics of SHR-2010 by intravenously/subcutaneously in Healthy Subject.
Phase:
Phase 1
Details
Lead Sponsor:
Guangdong Hengrui Pharmaceutical Co., Ltd